Correlation Between Arcutis Biotherapeutics and 89bio

Can any of the company-specific risk be diversified away by investing in both Arcutis Biotherapeutics and 89bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcutis Biotherapeutics and 89bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arcutis Biotherapeutics and 89bio Inc, you can compare the effects of market volatilities on Arcutis Biotherapeutics and 89bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcutis Biotherapeutics with a short position of 89bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcutis Biotherapeutics and 89bio.

Diversification Opportunities for Arcutis Biotherapeutics and 89bio

0.41

Correlation Coefficient

Arcutis Biotherapeutics  89bio

Very weak diversification

The 3 months correlation between Arcutis and 89bio is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Arcutis Biotherapeutics and 89bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 89bio Inc and Arcutis Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcutis Biotherapeutics are associated (or correlated) with 89bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 89bio Inc has no effect on the direction of Arcutis Biotherapeutics i.e., Arcutis Biotherapeutics and 89bio go up and down completely randomly.

Pair Corralation between Arcutis Biotherapeutics and 89bio

Given the investment horizon of 90 days Arcutis Biotherapeutics is expected to generate 0.89 times more return on investment than 89bio. However, Arcutis Biotherapeutics is 1.12 times less risky than 89bio. It trades about 0.07 of its potential returns per unit of risk. 89bio Inc is currently generating about 0.04 per unit of risk. If you would invest  1,050  in Arcutis Biotherapeutics on August 31, 2024 and sell it today you would earn a total of  121.00  from holding Arcutis Biotherapeutics or generate 11.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Arcutis Biotherapeutics  vs.  89bio Inc

Arcutis Biotherapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Arcutis Biotherapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Arcutis Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

89bio Inc

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in 89bio Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, 89bio may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Arcutis Biotherapeutics and 89bio

The main advantage of trading using opposite Arcutis Biotherapeutics and 89bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcutis Biotherapeutics position performs unexpectedly, 89bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 89bio will offset losses from the drop in 89bio's long position.

The idea behind Arcutis Biotherapeutics and 89bio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.